Valle Palomo

2.2k total citations
53 papers, 1.7k citations indexed

About

Valle Palomo is a scholar working on Molecular Biology, Pharmacology and Neurology. According to data from OpenAlex, Valle Palomo has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 11 papers in Pharmacology and 10 papers in Neurology. Recurrent topics in Valle Palomo's work include Cholinesterase and Neurodegenerative Diseases (11 papers), Phosphodiesterase function and regulation (10 papers) and Amyotrophic Lateral Sclerosis Research (9 papers). Valle Palomo is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (11 papers), Phosphodiesterase function and regulation (10 papers) and Amyotrophic Lateral Sclerosis Research (9 papers). Valle Palomo collaborates with scholars based in Spain, United States and Italy. Valle Palomo's co-authors include Ana Martı́nez, Carmen Gil, Daniel I. Pérez, Concepción Pérez, Philip E. Dawson, José Á. Morales-García, Ana Pérez‐Castillo, Sandra Alonso‐Gil, Hedi Mattoussi and Goutam Palui and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and ACS Nano.

In The Last Decade

Valle Palomo

52 papers receiving 1.7k citations

Peers

Countries citing papers authored by Valle Palomo

Since Specialization

Citations

This map shows the geographic impact of Valle Palomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valle Palomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valle Palomo more than expected).

Fields of papers citing papers by Valle Palomo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valle Palomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valle Palomo. The network helps show where Valle Palomo may publish in the future.

Co-authorship network of co-authors of Valle Palomo

This figure shows the co-authorship network connecting the top 25 collaborators of Valle Palomo. A scholar is included among the top collaborators of Valle Palomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valle Palomo. Valle Palomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis 2024 ·Neurobiology of Disease ·Eva P. Cuevas, Loreto Martínez‐González, (unknown), (unknown), (unknown), Amets Sáenz, Carmen Gil, Valle Palomo, Ángeles Martín‐Requero, Ana Martı́nez	9
2	Membrane-Targeted Quantum Dot-Based BACE1 Activity Sensors for In Vitro and In Cellulo Assays 2024 ·ACS Applied Materials & Interfaces ·(unknown), (unknown), Michael H. Stewart, Kimihiro Susumu, Igor L. Medintz, Sebastián A. Dı́az, Valle Palomo	2
3	TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients 2023 ·Frontiers in Molecular Neuroscience ·Loreto Martínez‐González, Eva P. Cuevas, (unknown), Vanesa Nozal, Carmen Gil, Valle Palomo, Ángeles Martín‐Requero, Ana Martı́nez	9
4	PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 2023 ·ACS Chemical Neuroscience ·(unknown), Letizia Pruccoli, (unknown), Angela De Simone, (unknown), Francesca Spyrakis, Flavia Frabetti, Elisa Uliassi, Vincenza Andrisano, (unknown), (unknown), Valle Palomo, María Laura Bolognesi, Andrea Tarozzi, Andrea Milelli	19
5	Evaluating the Catalytic Efficiency of the Human Membrane-type 1 Matrix Metalloproteinase (MMP-14) Using AuNP–Peptide Conjugates 2023 ·Journal of the American Chemical Society ·Zhicheng Jin, (unknown), Goutam Palui, Valle Palomo, Jesse V. Jokerst, Philip E. Dawson, Qing‐Xiang Amy Sang, Hedi Mattoussi	22
6	Quantum Dot–Peptide Conjugates as Energy Transfer Probes for Sensing the Proteolytic Activity of Matrix Metalloproteinase-14 2023 ·Analytical Chemistry ·Zhicheng Jin, (unknown), Goutam Palui, Valle Palomo, Jesse V. Jokerst, (unknown), Qing‐Xiang Amy Sang, Hedi Mattoussi	27
7	Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale 2023 ·Frontiers in Bioengineering and Biotechnology ·(unknown), (unknown), (unknown), (unknown), Sebastián A. Thompson, Begoña Sot, Gorka Salas, Álvaro Somoza, Ana Espinosa, Milagros Castellanos, Valle Palomo	1
8	Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function 2022 ·International Journal of Molecular Sciences ·María A. Oliva, (unknown), Lucía Barrado-Gil, (unknown), Inmaculada Galindo, Urtzi Garaigorta, (unknown), (unknown), Daniel Lucena‐Agell, Juan F. Giménez-Abián, Isabel García-Dorival, Jesús Urquiza, Pablo Gastaminza, J. Fernando Dı́az, Valle Palomo, Covadonga Alonso	9
9	TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy 2022 ·Journal of Medicinal Chemistry ·Vanesa Nozal, Loreto Martínez‐González, (unknown), (unknown), Paula Santana, A. Chaikuad, Eva P. Cuevas, Stefan Knapp, Daniel Lietha, David Ramírez, Sabrina Petralla, Barbara Monti, Carmen Gil, Ángeles Martín‐Requero, Valle Palomo, Eva de Lago, Ana Martı́nez	28
10	Efficient Assembly of Quantum Dots with Homogenous Glycans Derived from Natural N-Linked Glycoproteins 2018 ·Bioconjugate Chemistry ·Valle Palomo, Philip A. Cistrone, Naiqian Zhan, Goutam Palui, Hedi Mattoussi, Philip E. Dawson	6
11	Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa 2018 ·Molecular Neurodegeneration ·(unknown), Beatriz Villarejo‐Zori, Miguel Marchena, (unknown), Valle Palomo, Carmen Gil, Ignacio Lizasoaín, Pedro de la Villa, Ana Martı́nez, Enrique J. de la Rosa, Catalina Hernández‐Sánchez	33
12	Purple-, Blue-, and Green-Emitting Multishell Alloyed Quantum Dots: Synthesis, Characterization, and Application for Ratiometric Extracellular pH Sensing 2017 ·Chemistry of Materials ·Kimihiro Susumu, Lauren D. Field, Eunkeu Oh, Michael Hunt, James B. Delehanty, Valle Palomo, Philip E. Dawson, Alan L. Huston, Igor L. Medintz	72
13	Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis 2017 ·Scientific Reports ·Eva M. Medina‐Rodríguez, Ana Bribián, Amanda Boyd, Valle Palomo, Jesús Pastor, Alfonso Lagares, Carmen Gil, Ana Martı́nez, Anna Williams, Fernando de Castro	41
14	Inhibition of glycogen synthase kinase 3 prevents synaptic long-term depression and facilitates cognition in C57BL/6J mice 2016 ·Tatiana V. Lipina, (unknown), (unknown), (unknown), Valle Palomo, Daniel I. Pérez, Ana Martı́nez, John Roder	3
15	Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival 2013 ·Cellular and Molecular Life Sciences ·Eva M. Medina‐Rodríguez, Francisco Javier Arenzana, Jesús Pastor, Miriam Redondo, Valle Palomo, Rafael G. Sola, Carmen Gil, Ana Martı́nez, Ana Bribián, Fernando de Castro	50
16	The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury 2012 ·Journal of Neurochemistry ·Cristina Susín, José Á. Morales-García, Diana Aguilar‐Morante, Valle Palomo, Marina Sanz-SanCristóbal, Sandra Alonso‐Gil, Carmen Gil, Ángel Santos, Ana Martı́nez, Ana Pérez‐Castillo	16
17	Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo 2012 ·ACS Chemical Neuroscience ·José Á. Morales-García, (unknown), Sandra Alonso‐Gil, Marina Sanz-SanCristóbal, Valle Palomo, Carmen Gil, Ángel Santos, Ana Martı́nez, Ana Pérez‐Castillo	136
18	5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: Determination of blood–brain barrier penetration and binding to human serum albumin 2012 ·European Journal of Pharmaceutical Sciences ·Daniel I. Pérez, Marco Pistolozzi, Valle Palomo, Miriam Redondo, (unknown), Carmen Gil, Guy Félix, Ana Martı́nez, Carlo Bertucci	28
19	Dual inhibitor of PDE7 and GSK-3 – VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice 2012 ·Neuropharmacology ·Tatiana V. Lipina, Valle Palomo, Carmen Gil, Ana Martı́nez, John Roder	47
20	Exploring the Binding Sites of Glycogen Synthase Kinase 3. Identification and Characterization of Allosteric Modulation Cavities 2011 ·Journal of Medicinal Chemistry ·Valle Palomo, Ignacio Soteras, Daniel I. Pérez, Concepción Pérez, Carmen Gil, Nuria E. Campillo, Ana Martı́nez	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact